Literature DB >> 21076470

The actin-associating protein Tm5NM1 blocks mesenchymal motility without transition to amoeboid motility.

J G Lees1, C T T Bach, P Bradbury, A Paul, P W Gunning, G M O'Neill.   

Abstract

Cell migration is an integral component of metastatic disease. The ability of cells to transit between mesenchymal and amoeboid modes of migration has complicated the development of successful therapies designed to target cell migration as a means of inhibiting metastasis. Therefore, investigations of the mechanisms that regulate cell migration and render cells stationary are necessary. Tropomyosins are actin-associating proteins that regulate the activity of several effectors of actin filament dynamics. Previously, we have shown that the tropomyosin isoform Tm5NM1 stabilizes actin filaments and inhibits cell migration in a two-dimensional culture system. Here, we show that Tm5NM1 inhibits the mesenchymal migration of multiple cell lines in an isoform-specific manner. Tm5NM1 stimulates the downregulation of Src kinase activity and a rounded or elliptical morphology in three-dimensional collagen gels, and cells have dramatically reduced capacity to form pseudopodia. Importantly, we find that Tm5NM1 inhibits both the mesenchymal to amoeboid and amoeboid to mesenchymal transitions. Collectively, our data suggest that mimicking the action of Tm5NM1 overexpression represents an approach for effectively inhibiting the mesenchymal mode of migration.
© 2011 Macmillan Publishers Limited

Mesh:

Substances:

Year:  2010        PMID: 21076470     DOI: 10.1038/onc.2010.516

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  13 in total

1.  Tropomyosin isoforms and reagents.

Authors:  Galina Schevzov; Shane P Whittaker; Thomas Fath; Jim Jc Lin; Peter W Gunning
Journal:  Bioarchitecture       Date:  2011-07-01

Review 2.  Interior decoration: tropomyosin in actin dynamics and cell migration.

Authors:  Justin G Lees; Cuc T T Bach; Geraldine M O'Neill
Journal:  Cell Adh Migr       Date:  2011-03-01       Impact factor: 3.405

3.  Mixed Nanosized Polymeric Micelles as Promoter of Doxorubicin and miRNA-34a Co-Delivery Triggered by Dual Stimuli in Tumor Tissue.

Authors:  Giuseppina Salzano; Daniel F Costa; Can Sarisozen; Ed Luther; George Mattheolabakis; Pooja P Dhargalkar; Vladimir P Torchilin
Journal:  Small       Date:  2016-07-19       Impact factor: 13.281

4.  N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.

Authors:  Petra Van Damme; Marta Lasa; Bogdan Polevoda; Cristina Gazquez; Alberto Elosegui-Artola; Duk Soo Kim; Elena De Juan-Pardo; Kimberly Demeyer; Kristine Hole; Esther Larrea; Evy Timmerman; Jesus Prieto; Thomas Arnesen; Fred Sherman; Kris Gevaert; Rafael Aldabe
Journal:  Proc Natl Acad Sci U S A       Date:  2012-07-18       Impact factor: 11.205

5.  Scared stiff: Stabilizing the actin cytoskeleton to stop invading cancer cells in their tracks.

Authors:  Geraldine M O'Neill
Journal:  Bioarchitecture       Date:  2011-01

6.  Thymosin-β4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma.

Authors:  Belamy B Cheung; Owen Tan; Jessica Koach; Bing Liu; Michael S Y Shum; Daniel R Carter; Selina Sutton; Sela T Po'uha; Louis Chesler; Michelle Haber; Murray D Norris; Maria Kavallaris; Tao Liu; Geraldine M O'Neill; Glenn M Marshall
Journal:  Mol Oncol       Date:  2015-04-29       Impact factor: 6.603

7.  Tropomyosin Tm5NM1 spatially restricts src kinase activity through perturbation of Rab11 vesicle trafficking.

Authors:  Cuc T Bach; Rachael Z Murray; Dylan Owen; Kat Gaus; Geraldine M O'Neill
Journal:  Mol Cell Biol       Date:  2014-10-06       Impact factor: 4.272

8.  Rac GTPase regulation of 3D invasion in neuroblastomas lacking MYCN amplification.

Authors:  Camilla B Mitchell; Geraldine M O'Neill
Journal:  Cell Adh Migr       Date:  2016-05-25       Impact factor: 3.405

Review 9.  Actin binding proteins: their ups and downs in metastatic life.

Authors:  Stephane R Gross
Journal:  Cell Adh Migr       Date:  2013-01-09       Impact factor: 3.405

Review 10.  Movers and shakers: cell cytoskeleton in cancer metastasis.

Authors:  C M Fife; J A McCarroll; M Kavallaris
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.